Hazim Kadhim Selected Research

Hazim Kadhim Research Topics

Disease

11	Sudden Infant Death (SID) 08/2010 - 11/2003
8	Sleep Apnea Syndromes (Sleep Apnea) 12/2003 - 12/2003
5	Hypoxia (Hypoxemia) 11/2009 - 12/2003
3	Ischemia 11/2009 - 07/2008
2	Brain Injuries (Brain Injury) 11/2009 - 03/2009
2	Asphyxia (Suffocation) 03/2009 - 12/2003
2	Apnea 12/2003 - 12/2003
2	Central Sleep Apnea (Central Sleep Apnea Syndrome) 12/2003 - 12/2003
2	Infant Death 12/2003 - 12/2003
2	Gliosis 12/2003 - 09/2002
2	Cerebral Palsy (Spastic Diplegia) 03/2003 - 01/2002
1	Crohn Disease (Crohn's Disease) 02/2022
1	Necrosis 02/2022
1	Myalgia 02/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Glycogen Storage Disease (Glycogenosis) 01/2017
1	Sarcoidosis (Schaumann Disease) 01/2017
1	Mucopolysaccharidosis VII (Sly Syndrome) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016
1	Muscular Diseases (Myopathy) 05/2015
1	Hemimegalencephaly 03/2015
1	Infantile Epileptic-Dyskinetic Encephalopathy 03/2015
1	Bacterial Infections (Bacterial Infection) 03/2009
1	Inflammation (Inflammations) 07/2008
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2008
1	Metachromatic Leukodystrophy due to Saposin B Deficiency 01/2008
1	Seizures (Absence Seizure) 01/2006
1	Brain Edema (Cerebral Edema) 03/2005
1	Pain (Aches) 12/2003
1	Multiple Sclerosis 03/2003
1	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 03/2003
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 03/2003
1	Demyelinating Diseases (Demyelinating Disease) 03/2003

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2016 - 01/2002
3	LipopolysaccharidesIBA 11/2009 - 07/2008
3	Proteins (Proteins, Gene)FDA Link 07/2008 - 12/2003
2	Biological ProductsIBA 02/2022 - 08/2010
2	Interleukin-2 (IL2)IBA 08/2010 - 07/2008
2	Messenger RNA (mRNA)IBA 07/2008 - 07/2008
2	Interleukin-1 (Interleukin 1)IBA 07/2008 - 11/2003
2	Glial Fibrillary Acidic ProteinIBA 12/2003 - 09/2002
1	Infliximab (Remicade)FDA Link 02/2022
1	AntibodiesIBA 01/2017
1	Prostaglandins BIBA 01/2017
1	polyglucosanIBA 01/2017
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 05/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2008
1	EndotoxinsIBA 07/2008
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2008
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2008
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2006
1	ElementsIBA 03/2005
1	Serotonin ReceptorsIBA 12/2003
1	A-factor (Streptomyces)IBA 12/2003
1	Colloids (Colloid)IBA 12/2003
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2003
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2003
1	NeuropeptidesIBA 12/2003
1	tributyl phosphate (TBP)IBA 12/2003
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 12/2003
1	Serotonin (5 Hydroxytryptamine)IBA 12/2003
1	Substance PIBA 12/2003
1	Transcription Factors (Transcription Factor)IBA 12/2003
1	tau Proteins (tau Protein)IBA 12/2003
1	Ki-67 Antigen (Ki 67 Antigen)IBA 12/2003
1	UbiquitinIBA 12/2003
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 12/2003
1	InterleukinsIBA 11/2003

Therapy/Procedure

1	Therapeutics 02/2022
1	Hemispherectomy 03/2015